Theorem Clinical Research

Archives

Choose a date range

From To

Choose one or more categories

Categories:



Show only original CenterWatch stories

 


Time to Focus on Solutions for Sites—the last piece of the trial acceleration puzzle

Monday, October 20, 2014 08:00 AM

Over the last 20 years, the industry has focused on developing solutions to help streamline and accelerate the clinical trial process for two of the three main clinical trial stakeholders: sponsors/CROs and patients/volunteers.

More... »


Physicians to pharmas: provide patient services or face irrelevance

Friday, October 17, 2014 02:49 PM

Physicians are looking to pharmaceutical companies to help them keep patients engaged in their healthcare by providing patient services, according to the ePharma Physician 2014 study from Manhattan Research, part of Burlington, Mass.-based Decision Resources Group.

More... »


Study: strong consumer interest in storing, sharing health data

Friday, October 17, 2014 02:47 PM

As Apple, Samsung and Google field health and fitness data aggregators, 30% of online consumers would be interested in using such a service, and more than one-third would consider doing so if it saved them money.

More... »

Cardiorentis, Roche collaborate on Ularitide

Friday, October 17, 2014 12:49 PM

Cardiorentis, a Switzerland-based, privately held biopharmaceutical company, is collaborating with Roche to establish the therapeutic efficacy and safety of Ularitide, the company's investigational drug for acute heart failure (AHF). Cardiorentis will incorporate Roche's advanced in vitro diagnostic tests into its TRUE-AHF phase III study to characterize the pharmacological properties of Ularitide, evaluate its benefit-risk profile and the appropriate clinical application in patients.

More... »

Sanofi Pasteur, Immune Design collaborate on herpes simplex virus therapy

Friday, October 17, 2014 12:48 PM

Immune Design, a California-based clinical-stage immunotherapy company, has entered into a broad collaboration for the development of a herpes simplex virus (HSV) immune therapy with Sanofi Pasteur, the vaccines division of Sanofi.

More... »

AstraZeneca, University of Cambridge strengthen partnership

Friday, October 17, 2014 12:46 PM

AstraZeneca, together with its global biologics R&D arm MedImmune, has entered into four new collaborations with the University of Cambridge, building further on their existing partnership. The latest collaborations reinforce AZ’s commitment to creating a permeable research infrastructure in Cambridge following its decision to locate one of its three global R&D centers and its global headquarters in the city, which has been home to MedImmune’s biologics research laboratories for 25 years.

More... »

Aduro, Johnson & Johnson Innovation and Janssen expand collaboration

Friday, October 17, 2014 12:44 PM

Aduro BioTech, a Berkeley, Calif.-based, private, clinical-stage biotechnology company focused on immunotherapy for cancer, has entered into its second agreement with Janssen Biotech, part of Johnson & Johnson, granting an exclusive, worldwide license to certain product candidates engineered for the treatment of lung cancer and certain other cancers based on its novel LADD immunotherapy platform.

More... »

Bone Biologics completes merger with AFH Acquisition X

Friday, October 17, 2014 12:34 PM

Bone Biologics, a California-based company developing a proprietary protein for use in bone regenerative medicine using the patented recombinant human protein known as UCB-1 (or Nell-1) for use with patients undergoing spinal fusion, has completed a reverse merger with AFH Acquisition X, a fully-reporting company with the Securities and Exchange Commission. The combined company changed its name to Bone Biologics.

More... »

BBK acquires MEDL Mobile, company instrumental in developing its leading mobile app

Thursday, October 16, 2014 02:37 PM

BBK Holdings announced this morning it will acquire the custom application development division of MEDL Holdings, a developer of mobile applications that has been a long-time partner and collaborator in BBK’s mobile application for patient and site engagement, My Clinical Study Buddy.

More... »

Treeway, LACDR collaborate on ALS therapy development

Thursday, October 16, 2014 02:36 PM

Treeway, a Netherlands-based, amyotrophic lateral sclerosis (ALS) R&D strategy-focused company, and the Leiden Academic Center for Drug Research (LACDR) at the University of Leiden, the Netherlands, have formed a collaboration focused on the optimization of clinical trial designs and data analysis for ALS through the use of population disease progression models. Both parties aim to obtain a better understanding of the disease by developing ALS physiology-based disease models and test the effect of interventions in the different identified pathways.

More... »

CenterWatch Drugs in Clinical Trials
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

October 20

Toronto Star, with FDA data, exposes weaknesses in Health Canada's clinical trial, inspection oversight

Crowdsourcing effort aims to fund updated online social media guide for sponsor interaction with patients

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

September

Today's fastest, most economical sponsors
Standout sponsors reveal how they shorten regulatory, clinical cycle times

From the trenches: Sites' eye view of state of the industry
CW’s first site focus groups uncover frustration with 'progress,' but a passion for their mission

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

August

Reality of costs and impact rain on Sunshine Act
Concerns mount over compliance burden on CROs, sponsors, unanticipated consequences for research

Cloud computing expanding into all areas of clinical trial conduct
Benefits outweigh the complexities, challenges of finding right vendors

Already a subscriber?
Log in to your digital subscription.

Purchase the August issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs